✦ LIBER ✦

Tolerability of first-line therapy for metastatic renal cell carcinoma

✍ Scribed by Camillo Porta; Cezary Szczylik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Line Treatment Outcomes After Fir

✍ Chi-Chang Chen; Gregory P. Hess; Zhimei Liu; Dean H. Gesme; Sanjiv S. Agarwala; 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 284 KB

Targeted therapy for metastatic renal ce

✍ Patel, P H; Chaganti, R S K; Motzer, R J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Cost-effectiveness evaluation of sunitin

✍ Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Mar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 451 KB

Economic evaluation of new targeted ther

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Second-line therapy for refractory renal

✍ Fable Zustovich; Giuseppe Lombardi; Ornella Nicoletto; Davide Pastorelli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Defining risk status in the first-line t

✍ Manuela Schmidinger; Christoph C. Zielinski 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 340 KB